CEO with extensive and unique experience in leading complex technology transactions with Israeli and multinational companies in various fields.
Keren is an intellectual property expert with strong technological understanding, working closely with the industry, the Innovation Authority, Venture Capitals, Incubators, European Commission and other entities in initiating and structuring research collaboration, joint ventures and licensing transactions.
Keren led the formation of several funds that invest in promising technologies and the incorporation of multiple start-up companies and serves as board member at several of Tel-Aviv University’s spinoff companies, as well as at TAU Ventures.
With more than 15 years' experience in technology transfer, Tamar boasts a successful track record of bringing medical innovations from the lab to the marketplace. Tamar is the CEO of Hadasit, chair of Hadasit Bio Holdings (HBL, TASE: HDST) and a board member of Kahr Medical. Prior to joining Hadasit, Tamar served as VP of Marketing and Strategy at Ramot, the technology transfer company of Tel Aviv University, responsible for the company strategic alliances, marketing activities and commercialization. Tamar was the founder and CEO of Allergene Ltd., an Israeli drug development start-up company. Tamar received her MSc and PhD in cell biology from the Tel Aviv University School of Medicine.
1586161739.jpg)
1586163933.jpg)